More on ABOS
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.47 |
|
|||
| Open | $2.41 | ||||
| 52 Wk High | $0.23 | ||||
| 52 Wk Low | $0.00 | ||||
| Day High | $2.59 | ||||
| Day Low | $2.40 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 487,059 | ||||
- Form S-8 Acumen Pharmaceuticals,
- Form 10-Q Acumen Pharmaceuticals, For: Jun 30
- Acumen Pharmaceuticals, Inc. (ABOS) Misses Q2 EPS by 9c
- Form 8-K Acumen Pharmaceuticals, For: Aug 12
- Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights
- Acumen Pharmaceuticals to Report Second Quarter Financial Results on August 12, 2026
- Acumen Pharmaceuticals shares brain delivery antibody data at AAIC 2026
- Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026
- Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 202
- Form 4 Acumen Pharmaceuticals, For: Jun 15 Filed by: Porter Derrell
Entities mentioned with ABOS
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Stifel | View Related Stories »
- 13G | View Related Stories »
- BTIG | View Related Stories »
- Show More...
